Appointment of Chief Business Development Officer

Summary by AI BETAClose X

Oxford Nanopore Technologies plc announced the appointment of Sebastian Kronmueller as Chief Business Development Officer, effective January 4, 2027, who will be based in the United States and lead strategy and business development functions. Kronmueller joins from Philips, where he was Head of Strategy and Ventures, and previously held senior roles at Siemens Healthineers, bringing extensive experience in diagnostics, genomics, and biopharma, including acquisitions, divestments, licensing, and strategic partnerships. The company's CEO highlighted Kronmueller's strategic insight and hands-on experience as crucial for accelerating commercial growth and unlocking long-term opportunities.

Disclaimer*

UK 100

Latest directors dealings